We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$14.6B
AUM Growth
-$325M
Cap. Flow
-$723M
Cap. Flow %
-4.97%
Top 10 Hldgs %
7.37%
Holding
1,080
New
68
Increased
314
Reduced
422
Closed
79

Top Sells

Rank Stock Value
1
IMXI icon
International Money Express
IMXI
+$42M
2
OLN icon
Olin
OLN
+$40.2M
3
BC icon
Brunswick
BC
+$36.7M
4
AA icon
Alcoa
AA
+$33.9M
5
USCR
U S Concrete, Inc.
USCR
+$31.9M

Sector Composition

Rank Sector Weight
1 Industrials 24.2%
2 Technology 20.04%
3 Financials 15.03%
4 Consumer Discretionary 13.3%
5 Healthcare 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGLE
651
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$3.85M 0.03%
81,428
CSTR
652
DELISTED
CapStar Financial Holdings, Inc
CSTR
$3.84M 0.03%
+187,213
New +$3.76M
SRGA
653
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$3.82M 0.03%
91,524
-8,957
-9% -$459K
DVAX
654
DELISTED
Dynavax Technologies
DVAX
$3.81M 0.03%
386,800
GTLS
655
DELISTED
Chart Industries
GTLS
$3.8M 0.03%
26,000
+6,000
+30% +$880K
AAOI icon
656
Applied Optoelectronics
AAOI
$6.14B
$3.77M 0.03%
+445,000
New +$3.62M
HTBK
657
DELISTED
Heritage Commerce
HTBK
$3.77M 0.03%
+338,573
New +$4.03M
GROW icon
658
US Global Investors
GROW
$36.3M
$3.75M 0.03%
604,954
-18,400
-3% -$131K
PETQ
659
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$3.74M 0.03%
97,000
+18,000
+23% +$718K
LPSN icon
660
LivePerson
LPSN
$22M
$3.73M 0.03%
3,933
+1,066
+37% +$898K
FLXN
661
DELISTED
Flexion Therapeutics, Inc.
FLXN
$3.71M 0.03%
451,037
-106,400
-19% -$905K
AVAV icon
662
AeroVironment
AVAV
$7.19B
$3.67M 0.03%
36,650
+1,500
+4% +$165K
GABC icon
663
German American Bancorp
GABC
$1.93B
$3.64M 0.03%
97,856
-178,555
-65% -$7.48M
PRTS icon
664
CarParts.com
PRTS
$42.6M
$3.62M 0.02%
17,800
HRMY icon
665
Harmony Biosciences
HRMY
$2.08B
$3.62M 0.02%
+128,050
New +$3.84M
CLAR icon
666
Clarus
CLAR
$125M
$3.61M 0.02%
140,603
-35,100
-20% -$749K
CSLT
667
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$3.57M 0.02%
1,356,552
-1,766,000
-57% -$3.29M
SCR
668
DELISTED
Score Media and Gaming Inc. Class A Subordinate Voting Shares
SCR
$3.56M 0.02%
177,710
CMI icon
669
Cummins
CMI
$83.6B
$3.54M 0.02%
14,500
JOE icon
670
St. Joe Company
JOE
$3.55B
$3.52M 0.02%
78,800
LESL icon
671
Leslie's
LESL
$8.33M
$3.48M 0.02%
6,325
+550
+10% +$302K
NDSN icon
672
Nordson
NDSN
$16.4B
$3.47M 0.02%
15,796
CCNE icon
673
CNB Financial Corp
CCNE
$1.05B
$3.42M 0.02%
149,656
-29,704
-17% -$724K
NPTN
674
DELISTED
NEOPHOTONICS CORP
NPTN
$3.41M 0.02%
334,400
+18,518
+6% +$195K
FRST icon
675
Primis Financial Corp
FRST
$399M
$3.41M 0.02%
+223,355
New +$3.35M

Similar funds

Royce & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Royce & Associates held 1,080 positions worth $14.6B, down 2.2% from $14.9B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

Royce & Associates withdrew a net $723M in Q2 2021, closing 79 positions and reducing 422 holdings. Its most notable exit was Olin, an estimated $40.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in Organon & Co worth $16.5M.

  • Royce & Associates's largest Q2 2021 buy was Organon & Co: 546,803 shares worth $16.5M.
  • Royce & Associates added most to Vontier in Q2 2021, an estimated $50.7M increase.
  • Royce & Associates's biggest Q2 2021 reduction was International Money Express, cutting an estimated $42M.
  • Royce & Associates fully exited Olin in Q2 2021, selling an estimated $40.2M.
  • Royce & Associates's ten largest holdings make up 7.4% of its $14.6B portfolio in Q2 2021.
  • Royce & Associates opened 68 new positions and closed 79 in Q2 2021.
  • Royce & Associates's portfolio value fell 2.2% quarter-over-quarter to $14.6B.

Based on Royce & Associates's 13F filing for Q2 2021, filed 6 Aug 2021.